Clinical Trial Update: Gabapentin for Alcohol Withdrawal Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial investigating gabapentin for Alcohol Withdrawal Syndrome completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Mayo Clinic | Conditions: Alcohol Withdrawal Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2022-03-24